CCA Industries, Inc. Reports Results of Operations for the Quarter and Six Months ended May 31, 2025

Rhea-AI Summary

CCA Industries (OTC:CAWW), a health and beauty aids manufacturer, reported financial results for Q2 and H1 2025. The company achieved a significant turnaround, posting net income of $2,929 in Q2 2025 compared to a loss of $24,421 in Q2 2024. For H1 2025, net income reached $16,682 versus a loss of $269,831 in H1 2024.

EBITDA showed marked improvement, with Q2 2025 EBITDA of $68,677 (vs. $1,831 in Q2 2024) and H1 2025 EBITDA of $108,906 (vs. -$286,667 in H1 2024). However, revenues declined to $1.59M in Q2 2025 from $2.21M in Q2 2024, and H1 2025 revenues fell to $3.25M from $4.35M, partly due to supply-chain challenges.

Positive

• Turned profitable with Q2 2025 net income of $2,929 vs loss of $24,421 in Q2 2024
• Significant EBITDA improvement to $108,906 in H1 2025 from -$286,667 in H1 2024
• Successfully reduced expenses and maximized margins
• Achieved more stable financial platform for future brand investment

Negative

• Q2 2025 revenues declined 28.3% to $1.59M from $2.21M in Q2 2024
• H1 2025 revenues decreased 25.2% to $3.25M from $4.35M in H1 2024
• Ongoing supply-chain issues affecting sales in Q2 and expected to continue in Q3 2025
• Interest expenses increased in both Q2 and H1 2025 compared to 2024

FORT WASHINGTON, PA / ACCESS Newswire / July 15, 2025 / CCA Industries, Inc. (OTC:CAWW), announced today its results for the three months and six months ended May 31, 2025. The results can be found in the chart below.

The net income was $2,929 for the three months ending May 31, 2025, compared to a loss of $24,421 for the three months ending May 31, 2024. The net income was $16,682 for the six months ending May 31, 2025, compared to a loss of $269,831 for the six months ending May 31, 2024. As shown in the chart below, EBITDA for the second quarter of fiscal 2025 was a profit of $68,677 compared to EBITDA of $1,831 for the second quarter of fiscal 2024. EBITDA for the first six months of fiscal 2025 was a profit of $108,906 compared to an EBITDA loss of $286,667 for the first six months of fiscal 2024. Christopher Dominello, Chief Executive Officer, commented, "The financial results for both the quarter and year to date as of May 31, 2025, shows how the tremendous efforts of reducing expenses and maximizing margins has now taken effect in producing profits. This has put the Company on a much more stable financial platform and will enable us to invest in our brands in order to turn our focus on growing sales. We did have some supply-chain issues that impacted sales in the second quarter, and we will be managing through some in the third quarter as well but feel confident they are short term issues."

Further information, including the Unaudited Financial Statement for the first quarter, ended May 31, 2025, the Audited Financial Statements for the year ended November 30, 2024, and the Quarterly Disclosure Statement filed with the OTC, may be found on the Company's investor web site: www.ccainvestor.com

CCA Industries, Inc. manufactures and markets health and beauty aids, each under its individual brand name. The products include, principally, "Plus White" toothpaste and teeth whiteners, "Nutra Nail" nail care treatments, "Porcelana" skin care products, "Scar Zone" scar treatment products, "Sudden Change" anti-aging skin care products, brands, "Hair Off" depilatory products, "Lobe Miracle" earlobe protection products and "Neutein" brain health supplements.

Statements contained in the news release that are not historical facts are forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks and uncertainties, which would cause actual results to differ materially, from estimated results. No assurance can be given that the results in any forward-looking statement will be achieved, and actual results could be affected by one or more factors, which could cause them to differ materially. For these statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act.

 

CCA INDUSTRIES, INC.
Financial Results (Unaudited)

		Three months ended May 31,
		2025				2024
Revenues		$	1,585,567			$	2,210,566
Net Income (Loss)		$	2,929			$	(24,421	)
Income (Losses) Per Share:
Basic		$	0.00			$	(0.00	)
Diluted		$	0.00			$	(0.00	)
Weighted Average Common Shares Outstanding:
Basic			7,561,684				7,561,684
Diluted			7,665,355				7,580,949
EBITDA *		$	68,677			$	1,831
* Earnings before interest, taxes, depreciation and amortization
Reconciliation of net loss to EBITDA:
Net Income		$	2,929			$	(24,421	)
Provision for income taxes			30,671				(3,908	)
Interest expense			33,933				28,630
Depreciation and Amortization			1,143				1,530
EBITDA		$	68,677			$	1,831

 

CCA INDUSTRIES, INC.
Financial Results (Unaudited)

		For the six months ended
		2025				2024
Revenues		$	3,251,535			$	4,345,147
Net Income (Loss)		$	16,682			$	(269,831	)
Income (Losses) Per Share:
Basic		$	0.00			$	(0.04	)
Diluted		$	0.00			$	(0.04	)
Weighted Average Common Shares Outstanding:
Basic			7,561,684				7,561,684
Diluted			7,622,095				7,561,684
EBITDA *		$	108,906			$	(286,667	)
* Earnings before interest, taxes, depreciation and amortization
Reconciliation of net income (loss) to EBITDA:
Net Income		$	16,682			$	(269,831	)
Provision for income taxes			26,617				(77,428	)
Interest expense			63,737				57,581
Depreciation and Amortization			1,870				3,011
EBITDA		$	108,906			$	(286,667	)

Company Contact:
Stephen A. Heit
201-935-3232

SOURCE: CCA Industries, Inc.

View the original press release on ACCESS Newswire

FAQ

What was CCA Industries (CAWW) net income for Q2 2025?

CCA Industries reported a net income of $2,929 for Q2 2025, compared to a loss of $24,421 in Q2 2024, showing a significant turnaround in profitability.

How much did CAWW revenue decline in Q2 2025?

CAWW revenues declined by 28.3% to $1.59 million in Q2 2025, compared to $2.21 million in Q2 2024, primarily due to supply-chain issues.

What was CCA Industries EBITDA for the first half of 2025?

CCA Industries reported EBITDA of $108,906 for H1 2025, a substantial improvement from an EBITDA loss of $286,667 in H1 2024.

What brands does CCA Industries (CAWW) manufacture?

CCA Industries manufactures health and beauty brands including Plus White toothpaste, Nutra Nail treatments, Porcelana skin care, Scar Zone products, Sudden Change anti-aging products, Hair Off depilatory products, and Neutein brain supplements.

What caused the decline in CCA Industries sales for Q2 2025?

The company experienced supply-chain issues that impacted sales in Q2 2025, with management indicating these challenges are expected to continue into Q3 2025 but are considered short-term issues.